PLEASANTON, Calif.,
Oct. 6, 2014 /PRNewswire/
-- Thoratec Corporation (NASDAQ: THOR), a world leader in
device-based mechanical circulatory support therapies to save,
support and restore failing hearts, announced today that
Niamh Pellegrini has joined Thoratec
in the new role of President, North America.
This new position at Thoratec encompasses responsibility for all
commercial operations within North America. Ms. Pellegrini
has over twenty-five years of experience in the healthcare industry
through a broad range of operational and commercial leadership
positions primarily at Johnson and Johnson. Most recently,
Ms. Pellegrini held senior sales, marketing and general management
positions within the LifeScan and Acclarent business units of
Johnson and Johnson.
This appointment follows the recent addition of Vasant Padmanabhan to the new position of Senior
Vice President, Technical Operations, where he will have
responsibility for all product research, development and
manufacturing operations. Mr. Padmanabhan has extensive
experience in the cardiovascular medical device industry, including
various research and development leadership roles over the past
eighteen years at Medtronic, where he most recently held the
position of Vice President, Product Development, Implantable
Defibrillator Business.
"I am very pleased with these changes to Thoratec's management
team," said D. Keith Grossman,
President and Chief Executive Officer. "Each of Ms.
Pellegrini and Mr. Padmanabhan brings a demonstrated history of
delivering results and will help to position Thoratec for improved
operational execution and competitive performance going forward,"
Mr. Grossman added.
About Thoratec
Thoratec is a world leader in therapies to address
advanced-stage heart failure. The company's products include
the HeartMate II® LVAS (Left Ventricular Assist Systems)
and Thoratec® VAD (Ventricular Assist Device) with more
than 20,000 devices implanted in patients suffering from heart
failure. Thoratec also manufactures the CentriMag® and
PediMag®/PediVAS® product lines. Thoratec is
headquartered in Pleasanton,
California. For more information, visit the company's
website at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate and HeartMate II are
registered trademarks of Thoratec Corporation and HeartMate III,
HeartMate PHP, PVAD, IVAD and Pocket Controller are trademarks of
Thoratec Corporation. CentriMag and PediMag are registered
trademarks of Thoratec LLC, and PediVAS is a registered trademark
of Thoratec Switzerland GmbH.
The preceding paragraphs contain forward-looking statements
within the meaning of Sections 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934. These
forward-looking statements relate to, among other things, the
Company's future operations, its development of new products and
increase in shareholder value. These statements can be identified
by the words, "believes," "expect," "estimates," "potential,"
and other similar words. Actual results, events or performance
could differ materially from these forward-looking statements based
on a variety of factors, many of which are beyond Thoratec's
control. Therefore, readers are cautioned not to put undue reliance
on these statements. Investors are cautioned that all such
statements involve risks and uncertainties. Forward-looking
statements contained in this press release should be considered in
light these factors and those factors discussed from time to time
in Thoratec's public reports filed with the Securities and Exchange
Commission, such as those discussed under the heading, "Risk
Factors," in Thoratec's most recent annual report on Form 10-K,
quarterly reports on Form 10-Q, current reports on Form 8-K and
other SEC filings. These forward-looking statements speak only as
of the date hereof. Thoratec undertakes no obligation to publicly
release the results of any revisions to these forward-looking
statements that may be made to reflect events or circumstances
after the date hereof, or to reflect the occurrence of
unanticipated events.
SOURCE Thoratec Corporation